Stock EMMESSA6 EMMESSAR BIOTECH & NUTRITION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Emmessar Biotech & Nutrition Limited

Equities

EMMESSA6

INE634B01016

Market Closed - Bombay S.E.
Other stock markets
 03:30:54 31/05/2024 pm IST 		5-day change 1st Jan Change
39.95 INR +1.27% Intraday chart for Emmessar Biotech & Nutrition Limited -4.08% +49.63%
29/05 Emmessar Biotech & Nutrition Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
29/05 Emmessar Biotech & Nutrition Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 153.9 89.18 56.96 73.44 137.4 123.9
Enterprise Value (EV) 1 151.1 82.68 38.07 48.66 91.47 72.72
P/E ratio 16.8 x 16.7 x 7.56 x 5.07 x 29.3 x 24.6 x
Yield - - - - - -
Capitalization / Revenue 6.14 x 4.71 x 1.2 x 0.88 x 6.02 x 4.93 x
EV / Revenue 6.03 x 4.37 x 0.8 x 0.58 x 4.01 x 2.89 x
EV / EBITDA 18.1 x 13.3 x 4 x 2.21 x 8.93 x 8.82 x
EV / FCF -61.5 x 45.9 x 3.2 x 30.1 x 4.71 x 108 x
FCF Yield -1.63% 2.18% 31.2% 3.32% 21.2% 0.93%
Price to Book 5.16 x 2.54 x 1.34 x 1.29 x 2.23 x 1.86 x
Nbr of stocks (in thousands) 4,996 4,996 4,996 4,996 4,996 4,996
Reference price 2 30.80 17.85 11.40 14.70 27.50 24.80
Announcement Date 23/08/18 17/08/19 07/09/20 07/09/21 25/08/22 07/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 25.07 18.94 47.54 83.43 22.84 25.15
EBITDA 1 8.359 6.236 9.522 21.99 10.24 8.246
EBIT 1 7.853 5.45 8.944 21.41 9.315 7.31
Operating Margin 31.32% 28.78% 18.81% 25.66% 40.79% 29.07%
Earnings before Tax (EBT) 1 7.959 2.938 7.376 22.55 9.315 9.669
Net income 1 9.134 5.329 7.537 14.5 4.754 5.038
Net margin 36.44% 28.14% 15.85% 17.38% 20.82% 20.03%
EPS 2 1.828 1.067 1.509 2.902 0.9400 1.008
Free Cash Flow 1 -2.457 1.801 11.88 1.616 19.43 0.6758
FCF margin -9.8% 9.51% 25% 1.94% 85.07% 2.69%
FCF Conversion (EBITDA) - 28.88% 124.81% 7.35% 189.75% 8.19%
FCF Conversion (Net income) - 33.79% 157.67% 11.15% 408.7% 13.41%
Dividend per Share - - - - - -
Announcement Date 23/08/18 17/08/19 07/09/20 07/09/21 25/08/22 07/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 2.75 6.5 18.9 24.8 45.9 51.2
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -2.46 1.8 11.9 1.62 19.4 0.68
ROE (net income / shareholders' equity) 36% 16.4% 19.4% 29.1% 8.01% 7.85%
ROA (Net income/ Total Assets) 13.8% 7.5% 9.9% 19.2% 7.75% 6.03%
Assets 1 66.38 71.03 76.15 75.51 61.32 83.57
Book Value Per Share 2 5.970 7.020 8.530 11.40 12.30 13.30
Cash Flow per Share 2 0.0800 0.1600 0.1000 1.050 9.180 0.0200
Capex 1 7.77 0.01 0.01 0.02 3.06 0.26
Capex / Sales 30.99% 0.04% 0.01% 0.02% 13.38% 1.05%
Announcement Date 23/08/18 17/08/19 07/09/20 07/09/21 25/08/22 07/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. EMMESSA6 Stock
  4. Financials Emmessar Biotech & Nutrition Limited